Key facts
- It has raised $8.0M; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include MassChallenge, EIT Food, StartLife, Darkboot, Lever VC — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Gavan
- ·The full record, as it builds
Funding rounds
No funding rounds for Gavan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gavan
Developer of plant-based protein extraction technology designed for sustainable food production. The company's platform utilizes proprietary technology to extract high-purity proteins from plants while preserving their natural structure and functionality, enabling the food industry to produce healthier and environmentally friendly products without relying on animal-derived ingredients.
- Sector
- Healthcare
- HQ
- Acre, Israel
- Founded
- 2018
- Employees
- 18
- Website
- gavan.bio/
- Ownership
- Privately Held (backing)
Gavan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gavan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gavan in its N-PORT filings yet. We sweep new filings monthly.